No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls

Teresa Coccini, Luigi Manzo, Frodi Debes, Ulrike Steuerwald, Pl Weihe, Philippe Grandjean

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Experimental evidence suggests that monoamine oxidase B (MAO-B) and muscarinic cholinergic receptors (mAChRs) are involved in the pathogenesis of neurotoxicity caused by methylmercury and polychlorinated biphenyls (PCBs). Blood samples from 7-year-old exposed children were analyzed for platelet MAO-B and lymphocyte mAChRs as potential markers of exposure to these neurotoxicants. The blood neurotoxicity biomarkers were compared with prenatal and current exposures and with neuropsychological test results. Both biomarkers showed homogeneous distributions within this cohort (mAChR, range 0.0436.78fmol/million cells; MAO-B, 0.9514.95nmol mg-1 protein h-1). No correlation was found between the two biomarkers and either blood neurotoxicant concentrations or clinical findings. MAO-B and mAChR sensitivity may not be sufficiently high to assess early, subclinical responses to low/moderate methylmercury and/or PCB exposure, whereas these markers are significantly altered in sustained exposure scenarios, as shown by clinical studies in drug addicts or patients treated with psychopharmacological agents.

Original languageEnglish
Pages (from-to)67-76
Number of pages10
JournalBiomarkers
Volume14
Issue number2
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Lymphocytes
Polychlorinated Biphenyls
Monoamine Oxidase
Neurology
Biomarkers
Muscarinic Receptors
Platelets
Blood Platelets
Central Nervous System
Blood
Cholinergic Receptors
Cholinergic Agents
Neuropsychological Tests
Drug Users
B-Lymphocytes
Pharmaceutical Preparations
Proteins

Keywords

  • Brain development
  • Cholinergic receptors
  • MAO-B
  • MeHg
  • Neurochemical markers
  • Polychlorinated biphenyls

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis
  • Medicine(all)

Cite this

No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls. / Coccini, Teresa; Manzo, Luigi; Debes, Frodi; Steuerwald, Ulrike; Weihe, Pl; Grandjean, Philippe.

In: Biomarkers, Vol. 14, No. 2, 03.2009, p. 67-76.

Research output: Contribution to journalArticle

@article{bd9548061371439fb6f633943bb7956a,
title = "No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls",
abstract = "Experimental evidence suggests that monoamine oxidase B (MAO-B) and muscarinic cholinergic receptors (mAChRs) are involved in the pathogenesis of neurotoxicity caused by methylmercury and polychlorinated biphenyls (PCBs). Blood samples from 7-year-old exposed children were analyzed for platelet MAO-B and lymphocyte mAChRs as potential markers of exposure to these neurotoxicants. The blood neurotoxicity biomarkers were compared with prenatal and current exposures and with neuropsychological test results. Both biomarkers showed homogeneous distributions within this cohort (mAChR, range 0.0436.78fmol/million cells; MAO-B, 0.9514.95nmol mg-1 protein h-1). No correlation was found between the two biomarkers and either blood neurotoxicant concentrations or clinical findings. MAO-B and mAChR sensitivity may not be sufficiently high to assess early, subclinical responses to low/moderate methylmercury and/or PCB exposure, whereas these markers are significantly altered in sustained exposure scenarios, as shown by clinical studies in drug addicts or patients treated with psychopharmacological agents.",
keywords = "Brain development, Cholinergic receptors, MAO-B, MeHg, Neurochemical markers, Polychlorinated biphenyls",
author = "Teresa Coccini and Luigi Manzo and Frodi Debes and Ulrike Steuerwald and Pl Weihe and Philippe Grandjean",
year = "2009",
month = "3",
doi = "10.1080/13547500902783739",
language = "English",
volume = "14",
pages = "67--76",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls

AU - Coccini, Teresa

AU - Manzo, Luigi

AU - Debes, Frodi

AU - Steuerwald, Ulrike

AU - Weihe, Pl

AU - Grandjean, Philippe

PY - 2009/3

Y1 - 2009/3

N2 - Experimental evidence suggests that monoamine oxidase B (MAO-B) and muscarinic cholinergic receptors (mAChRs) are involved in the pathogenesis of neurotoxicity caused by methylmercury and polychlorinated biphenyls (PCBs). Blood samples from 7-year-old exposed children were analyzed for platelet MAO-B and lymphocyte mAChRs as potential markers of exposure to these neurotoxicants. The blood neurotoxicity biomarkers were compared with prenatal and current exposures and with neuropsychological test results. Both biomarkers showed homogeneous distributions within this cohort (mAChR, range 0.0436.78fmol/million cells; MAO-B, 0.9514.95nmol mg-1 protein h-1). No correlation was found between the two biomarkers and either blood neurotoxicant concentrations or clinical findings. MAO-B and mAChR sensitivity may not be sufficiently high to assess early, subclinical responses to low/moderate methylmercury and/or PCB exposure, whereas these markers are significantly altered in sustained exposure scenarios, as shown by clinical studies in drug addicts or patients treated with psychopharmacological agents.

AB - Experimental evidence suggests that monoamine oxidase B (MAO-B) and muscarinic cholinergic receptors (mAChRs) are involved in the pathogenesis of neurotoxicity caused by methylmercury and polychlorinated biphenyls (PCBs). Blood samples from 7-year-old exposed children were analyzed for platelet MAO-B and lymphocyte mAChRs as potential markers of exposure to these neurotoxicants. The blood neurotoxicity biomarkers were compared with prenatal and current exposures and with neuropsychological test results. Both biomarkers showed homogeneous distributions within this cohort (mAChR, range 0.0436.78fmol/million cells; MAO-B, 0.9514.95nmol mg-1 protein h-1). No correlation was found between the two biomarkers and either blood neurotoxicant concentrations or clinical findings. MAO-B and mAChR sensitivity may not be sufficiently high to assess early, subclinical responses to low/moderate methylmercury and/or PCB exposure, whereas these markers are significantly altered in sustained exposure scenarios, as shown by clinical studies in drug addicts or patients treated with psychopharmacological agents.

KW - Brain development

KW - Cholinergic receptors

KW - MAO-B

KW - MeHg

KW - Neurochemical markers

KW - Polychlorinated biphenyls

UR - http://www.scopus.com/inward/record.url?scp=66149097062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149097062&partnerID=8YFLogxK

U2 - 10.1080/13547500902783739

DO - 10.1080/13547500902783739

M3 - Article

C2 - 19330584

AN - SCOPUS:66149097062

VL - 14

SP - 67

EP - 76

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 2

ER -